Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 3NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Meningioma 2Leukemia, Myeloid, Chronic-Phase 1Leukemia 1Brain Neoplasms 1

Interventions

nilotinib 3bosutinib 2Imatinib Mesylate 2Filgrastim 2Dasatinib 2Cytogenetic Analysis 2ruxolitinib 1pembrolizumab 1liposomal amphotericin B 1asciminib 1Watchful Waiting 1Vancomycin 1Tyrosine Kinase Inhibitors 1Transplantation 1Tazobactam 1Specimen Handling 1Polymerase Chain Reaction 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Pharmaceutical Preparations 1Peripheral Blood Stem Cell Transplantation 1Moxifloxacin 1Morphine 1Microscopy 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1Methylprednisolone 1Interferon-alpha 1In Situ Hybridization, Fluorescence 1Idarubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Myeloid, Chronic-Phase × Hydroxyurea × Clear all
NCT00002868 2023-06-22

Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Eastern Cooperative Oncology Group

Phase 3 Completed
744 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡